bioAffinity Technologies (BIAF) Non-Current Debt (2024 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Non-Current Debt of $38915.0 for Q1 2026, down 19.19% year-over-year from $48156.0 in Q1 2025, and down 5.8% quarter-over-quarter from $41313.0 in Q4 2025.
bioAffinity Technologies (BIAF) Non-Current Debt (2024 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Non-Current Debt for 3 consecutive years, with $38915.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Debt fell 19.19% year-over-year to $38915.0; the TTM figure through Mar 2026 stood at $38915.0 (down 19.19% YoY), while the FY2025 annual figure was $41313.0, up 104.72% from the prior year.
- Non-Current Debt fell to $38915.0 in Q1 2026 per BIAF's latest filing, from $41313.0 in the prior quarter.
- Across five years, Non-Current Debt topped out at $48156.0 in Q1 2025 and bottomed at $20180.0 in Q4 2024.
- Historically, Non-Current Debt has averaged $33961.8 across 3 years, with a median of $38915.0 in 2026.
- Annual changes were most pronounced in 2025 — Non-Current Debt jumped 109.04% — and 2026, when it declined 19.19%.
- bioAffinity Technologies' Non-Current Debt stood at $20180.0 in 2024, then surged by 104.72% to $41313.0 in 2025, then decreased by 5.8% to $38915.0 in 2026.
- Business Quant data shows BIAF's Non-Current Debt at $38915.0 in Q1 2026, $41313.0 in Q4 2025, and $43658.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 42.28 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 25.15 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 299.87 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 3.05 Bn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 13.71 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | - |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 1.49 Bn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 2.04 Bn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 5.64 Bn |
| 10 | bioAffinity Technologies | 2.38 Mn | -721,990.64 | - | 38,915.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38,915.00 |
| Dec 31, 2025 | 41,313.00 |
| Sep 30, 2025 | 43,658.00 |
| Jun 30, 2025 | 45,952.00 |
| Mar 31, 2025 | 48,156.00 |
| Dec 31, 2024 | 20,180.00 |
| Sep 30, 2024 | 21,679.00 |
| Jun 30, 2024 | 22,766.00 |
| Mar 31, 2024 | 23,037.00 |